Which has grown faster, MRNA or WST?

Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus WST at 5.68%.

Does MRNA or WST pay a bigger dividend?

WST pays a dividend (0.25% yield), while MRNA has no payments in the available dividend history.

Is MRNA or WST more profitable?

WST runs the higher net margin — MRNA at -141.43% versus WST at 16.98%.

How have MRNA and WST total returns compared?

Over the past 5 years, MRNA delivered -33.41% and WST delivered 16.17% annualized total return. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of Moderna, Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.

MRNA

Moderna, Inc.

$24.03B

$60.57HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

WST

West Pharmaceutical Services, Inc.

$24.73B

$351.37HealthcareDelayed quote: Aug 11, 2026, 4:02 PM EDT

Total return — MRNA vs WST

growth of $100 · dividends reinvested · last 8y

MRNA +221.6% (+15.7%/yr)WST +239.9% (+16.5%/yr)WST compounded faster over this window

MRNA WST

MRNA vs WST: by the numbers

•WST is the larger company ($24.73B vs $24.03B market cap).
•WST is profitable (16.98% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 5.68% CAGR).
•WST pays a dividend (0.25% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MRNA	WST
P/E ratio	N/A	45.03
Forward P/E	N/A	39.38
P/S ratio	10.63	7.55
P/B ratio	3.50	8.40
EV / EBITDA	N/A	28.82
FCF yield	N/A	1.74%

Profitability

Metric	MRNA	WST
Gross margin	55.35%	36.77%
Operating margin	-158.13%	20.64%
Net margin	-141.43%	16.98%
ROE	-46.61%	18.89%
ROIC	-29.70%	13.62%

Dividends

Metric	MRNA	WST
Dividend yield	N/A	0.25%
Payout ratio	N/A	12.88%

Growth (annualized)

Metric	MRNA	WST
Revenue CAGR (5Y)	19.33%	5.68%
EPS CAGR (5Y)	N/A	7.85%
FCF CAGR (5Y)	N/A	8.74%
Total return CAGR (5Y)	-33.41%	-3.44%

Frequently asked

Which has grown faster, MRNA or WST?: Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus WST at 5.68%.
Does MRNA or WST pay a bigger dividend?: WST pays a dividend (0.25% yield), while MRNA has no payments in the available dividend history.
Is MRNA or WST more profitable?: WST runs the higher net margin — MRNA at -141.43% versus WST at 16.98%.
How have MRNA and WST total returns compared?: Over the past 5 years, MRNA delivered -33.41% and WST delivered 16.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full WST analysis Interactive comparison tool

Dig into the metrics

West Pharmaceutical Services P/E ratio West Pharmaceutical Services dividend yield Moderna ROE West Pharmaceutical Services ROE Moderna operating margin West Pharmaceutical Services operating margin Moderna revenue growth West Pharmaceutical Services revenue growth Moderna free cash flow West Pharmaceutical Services free cash flow

Moderna & West Pharmaceutical Services appear in these rankings

25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.